Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-LAMTOR3 antibody (30-110 aa) (STJ191720) | Login | Anti-LAMTOR3 antibody (30-110 aa) (STJ191720) | ||||||||||||||||
|
||||||||||||||||||
Anti-AKAP4 antibody (430-510 aa) (STJ191736) | Login | Anti-AKAP4 antibody (430-510 aa) (STJ191736) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDC42BPG antibody (1370-1450 aa) (STJ191748) | Login | Anti-CDC42BPG antibody (1370-1450 aa) (STJ191748) | ||||||||||||||||
|
||||||||||||||||||
Anti-GKN2 antibody (30-110 aa) (STJ191757) | Login | Anti-GKN2 antibody (30-110 aa) (STJ191757) | ||||||||||||||||
|
||||||||||||||||||
Anti-TGM4 antibody (160-240 aa) (STJ191228) | Login | Anti-TGM4 antibody (160-240 aa) (STJ191228) | ||||||||||||||||
|
||||||||||||||||||
Anti-SFTPD antibody (290-370 aa) (STJ191230) | Login | Anti-SFTPD antibody (290-370 aa) (STJ191230) | ||||||||||||||||
|
||||||||||||||||||
Anti-RABGAP1 antibody (260-340 aa) (STJ191236) | Login | Anti-RABGAP1 antibody (260-340 aa) (STJ191236) | ||||||||||||||||
|
||||||||||||||||||
Anti-RGPD5/RGPD6 antibody (1560-1640 aa) (STJ191249) | Login | Anti-RGPD5/RGPD6 antibody (1560-1640 aa) (STJ191249) | ||||||||||||||||
|
||||||||||||||||||
Anti-RAP1GDS1 antibody (230-310 aa) (STJ191254) | Login | Anti-RAP1GDS1 antibody (230-310 aa) (STJ191254) | ||||||||||||||||
|
||||||||||||||||||
Anti-RASA4 antibody (100-180 aa) (STJ191257) | Login | Anti-RASA4 antibody (100-180 aa) (STJ191257) | ||||||||||||||||
|
||||||||||||||||||
Anti-RASGEF1A antibody (130-210 aa) (STJ191262) | Login | Anti-RASGEF1A antibody (130-210 aa) (STJ191262) | ||||||||||||||||
|
||||||||||||||||||
Anti-RAC3 antibody (80-160 aa) (STJ191267) | Login | Anti-RAC3 antibody (80-160 aa) (STJ191267) | ||||||||||||||||
|
||||||||||||||||||
Anti-RAB23 antibody (120-200 aa) (STJ191276) | Login | Anti-RAB23 antibody (120-200 aa) (STJ191276) | ||||||||||||||||
|
||||||||||||||||||
Anti-RRAS2 antibody (90-170 aa) (STJ191296) | Login | Anti-RRAS2 antibody (90-170 aa) (STJ191296) | ||||||||||||||||
|
||||||||||||||||||
Anti-PTPRB antibody (280-360 aa) (STJ191297) | Login | Anti-PTPRB antibody (280-360 aa) (STJ191297) | ||||||||||||||||
|
||||||||||||||||||
Anti-PTPRD antibody (510-590 aa) (STJ191298) | Login | Anti-PTPRD antibody (510-590 aa) (STJ191298) | ||||||||||||||||
|
||||||||||||||||||
Anti-PTPRK antibody (180-260 aa) (STJ191300) | Login | Anti-PTPRK antibody (180-260 aa) (STJ191300) | ||||||||||||||||
|
||||||||||||||||||
Anti-PTPRS antibody (320-400 aa) (STJ191301) | Login | Anti-PTPRS antibody (320-400 aa) (STJ191301) | ||||||||||||||||
|
||||||||||||||||||
Anti-PTPRU antibody (270-350 aa) (STJ191303) | Login | Anti-PTPRU antibody (270-350 aa) (STJ191303) | ||||||||||||||||
|
||||||||||||||||||
Anti-ABCA4 antibody (630-710 aa) (STJ191313) | Login | Anti-ABCA4 antibody (630-710 aa) (STJ191313) | ||||||||||||||||
|
||||||||||||||||||
Anti-RBBP6 antibody (270-350 aa) (STJ191314) | Login | Anti-RBBP6 antibody (270-350 aa) (STJ191314) | ||||||||||||||||
|
||||||||||||||||||
Anti-ARHGAP24 antibody (550-630 aa) (STJ191318) | Login | Anti-ARHGAP24 antibody (550-630 aa) (STJ191318) | ||||||||||||||||
|
||||||||||||||||||
Anti-RHPN2 antibody (110-190 aa) (STJ191329) | Login | Anti-RHPN2 antibody (110-190 aa) (STJ191329) | ||||||||||||||||
|
||||||||||||||||||
Anti-RHOXF1 antibody (110-190 aa) (STJ191336) | Login | Anti-RHOXF1 antibody (110-190 aa) (STJ191336) | ||||||||||||||||
|
||||||||||||||||||
Anti-SPDEF antibody (140-220 aa) (STJ191350) | Login | Anti-SPDEF antibody (140-220 aa) (STJ191350) | ||||||||||||||||
|